ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 1 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,323,000 | -14.4% | 6,329,202 | 0.0% | 0.03% | -24.4% |
| Q2 2022 | $1,546,000 | -14.4% | 6,329,202 | 0.0% | 0.04% | 0.0% |
| Q1 2022 | $1,807,000 | -49.0% | 6,329,202 | +0.1% | 0.04% | -45.1% |
| Q4 2021 | $3,544,000 | -9.0% | 6,325,902 | +65.6% | 0.08% | 0.0% |
| Q3 2021 | $3,896,000 | -25.5% | 3,819,402 | +0.8% | 0.08% | -20.4% |
| Q2 2021 | $5,228,000 | -18.8% | 3,788,757 | +0.1% | 0.10% | -26.4% |
| Q1 2021 | $6,435,000 | +37.2% | 3,785,457 | +0.1% | 0.14% | +41.4% |
| Q4 2020 | $4,690,000 | -12.5% | 3,782,457 | +0.2% | 0.10% | -27.2% |
| Q3 2020 | $5,358,000 | – | 3,773,585 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |